BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Nelson Yee, Eugene Lengerich, Kathryn Schmitz, Jennifer Maranki, Niraj Gusani, Leila Tchelebi, Heath Mackley, Karen Krok, Maria Baker, Claire Boer, Julian Yee. Frontiers in Gastrointestinal Oncology: Advances in Multi-Disciplinary Patient CareBiomedicines 2018; 6(2): 64 doi: 10.3390/biomedicines6020064
2
Urvi A. Shah, Amara G. Nandikolla, Lakshmi Rajdev. Immunotherapeutic Approaches to Biliary CancerCurrent Treatment Options in Oncology 2017; 18(7) doi: 10.1007/s11864-017-0486-9
3
Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single InstitutionCancer Research and Treatment 2017; 49(2): 473 doi: 10.4143/crt.2016.166
4
Amir A. Rahnemai-Azar, Allison B. Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: current management and emerging therapiesExpert Review of Gastroenterology & Hepatology 2017; 11(5): 439 doi: 10.1080/17474124.2017.1309290
5
Alex B. Blair, Adrian Murphy. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the futureCurrent Problems in Cancer 2018; 42(1): 49 doi: 10.1016/j.currproblcancer.2017.10.004
6
David Goldstein, Charlotte Lemech, Juan Valle. New molecular and immunotherapeutic approaches in biliary cancerESMO Open 2017; 2(Suppl 1): e000152 doi: 10.1136/esmoopen-2016-000152
7
Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Alexander Lim, Richard Kim. Novel targeted treatment options for advanced cholangiocarcinomaExpert Opinion on Investigational Drugs 2018; 27(9): 709 doi: 10.1080/13543784.2018.1512581
8
Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda. Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancerJournal for ImmunoTherapy of Cancer 2020; 8(1): e000564 doi: 10.1136/jitc-2020-000564
9
Luxi Yin, Qi Xu, Jingjing Li, Qing Wei, Jieer Ying. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancerMedicine 2018; 97(50): e13570 doi: 10.1097/MD.0000000000013570
10
Toshifumi Wakai, Masayuki Nagahashi, Yoshifumi Shimada, Pankaj Prasoon, Jun Sakata. Genetic analysis in the clinical management of biliary tract cancerAnnals of Gastroenterological Surgery 2020;  doi: 10.1002/ags3.12334
11
Aileen Deng, Steven Cohen. Primary and Metastatic Liver Tumors2018; : 137 doi: 10.1007/978-3-319-91977-5_11
12
A. M. Matilla Peña, A. Clemente Sánchez, E. Ramón Botella, D. Rincón. ColangiocarcinomaMedicine - Programa de Formación Médica Continuada Acreditado 2020; 13(12): 666 doi: 10.1016/j.med.2020.06.020
13
Anwaar Saeed, Robin Park, Mohammed Al-Jumayli, Raed Al-Rajabi, Weijing Sun. Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced CholangiocarcinomaClinical Colorectal Cancer 2019; 18(2): 81 doi: 10.1016/j.clcc.2019.02.005